4 Inventories, net
Schedule
of inventories, net
| | |
2025 | | |
2024 | |
| | |
As of June 30, | |
| | |
2025 | | |
2024 | |
| | |
US$ | | |
US$ | |
| | |
| | |
| |
| Medicines and medical devices | |
| 106,415 | | |
| 188,274 | |
| Less: Allowance for stock obsolescence | |
| (2,501 | ) | |
| (24,281 | ) |
| Total inventories, net | |
| 103,914 | | |
| 163,993 | |
Movements
of allowance for stock obsolescence are as follows:
Schedule
of allowance for stock obsolescence
| | |
2025 | | |
2024 | |
| | |
As of June 30, | |
| | |
2025 | | |
2024 | |
| | |
US$ | | |
US$ | |
| | |
| | |
| |
| Allowance for stock obsolesces, beginning balance | |
| 24,281 | | |
| 24,331 | |
| Reversal | |
| (21,172 | ) | |
| - | |
| Exchange difference | |
| (608 | ) | |
| (50 | ) |
| Allowance for stock obsolesces ending balance | |
| 2,501 | | |
| 24,281 | |
There
are no inventories pledged as security for liabilities.
|